A European biotech developing a new cocrystal-based drug candidate required guidance for intellectual property protection.
Strategic patent support for a novel cocrystal API
A European biotech developing a new cocrystal-based drug candidate required guidance for intellectual property protection.
His understanding of polymorphic behavior and crystal form control resolved months of instability issues.
His understanding of polymorphic behavior and crystal form control resolved months of instability issues.
Fill out the form below, and we’ll schedule a consultation to discuss your solid-state challenges.